GPR41/43 mediates the inhibitory effects of acetate on IL-6 and IL-8, as well as propionate or butyrate on IL-6 production, while HDI activity underlies their suppression of vascular adhesion molecules and PBMC adhesion, mitigating atherosclerosis risk [75–77]. Here, IL6 is linked to atherosclerosis.